दवाओं की अंतःक्रिया
Natalizumab + Ublituximab
गंभीरता: गंभीर
Natalizumab and Ublituximab: major interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Natalizumab limits immune cell entry into tissues including the CNS, and ublituximab depletes B cells. Together they may increase the risk of serious infections, including progressive multifocal leukoencephalopathy.
इस इंटरैक्शन का सरल भाषा में अर्थ
Natalizumab and Ublituximab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Natalizumab belongs to Gastrointestinal Tract; Ublituximab belongs to Miscellaneous.
ऐसा क्यों होता है
Additive immunosuppression through blocked leukocyte trafficking plus CD20 B-cell depletion.
क्या करें
Avoid concurrent use. When switching, plan the washout using the effect duration of the first agent, and monitor for infection and new neurological symptoms.
फार्मासिस्ट से क्या पूछें
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Natalizumab और Ublituximab की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 7 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Natalizumab के अन्य इंटरैक्शन
Ublituximab के अन्य इंटरैक्शन
अक्सर पूछे जाने वाले प्रश्न
Can I take Natalizumab with Ublituximab?
MediHelp rates the interaction as major. Natalizumab and Ublituximab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Natalizumab limits immune cell entry into tissues including the CNS, and ublituximab depletes B cells. Together they may increase the risk of serious infections, including progressive multifocal leukoencephalopathy.
How serious is the interaction between Natalizumab and Ublituximab?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use. When switching, plan the washout using the effect duration of the first agent, and monitor for infection and new neurological symptoms.
What other medicines interact with Natalizumab?
MediHelp also lists interactions of Natalizumab with, for example, Vedolizumab, Axicabtagene ciloleucel, Baricitinib. The full list is on the Natalizumab page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
